Inventiva (IVA) Current Deferred Revenue (2018 - 2024)

Inventiva (IVA) posted quarterly Current Deferred Revenue of $3230.7 for Q2 2024, down 50.55% year-over-year from $6533.5 in Q3 2023, and down 49.96% quarter-over-quarter from $6455.6 in Q4 2023.

Inventiva (IVA) Current Deferred Revenue (2018 - 2024) Analysis & Trends

Inventiva's Current Deferred Revenue history runs 4 years deep, the most recent figure standing at $3230.7 for Q2 2024.

  • In Q2 2024, Current Deferred Revenue fell 50.55% year-over-year to $3230.7; the TTM figure through Jun 2024 stood at $3230.7 (down 50.55% YoY), while the FY2023 annual figure was $6455.6, up 5.46% from the prior year.
  • Current Deferred Revenue for Q2 2024 stood at $3230.7, down from $6455.6 in the prior quarter.
  • The five-year high for Current Deferred Revenue was $6533.5 in Q2 2023, with the low at $3230.7 in Q2 2024.
  • The 3-year median for Current Deferred Revenue is $6288.6 (2022), against an average of $5585.3.
  • The sharpest annual moves came in 2023 and 2024: Current Deferred Revenue rose 5.46% in 2023, then tumbled 50.55% in 2024.
  • Inventiva's Current Deferred Revenue stood at $6121.5 in 2022, then climbed by 5.46% to $6455.6 in 2023, then slumped by 49.96% to $3230.7 in 2024.
  • Business Quant data shows IVA's Current Deferred Revenue at $3230.7 in Q2 2024, $6455.6 in Q4 2023, and $6533.5 in Q2 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Inventiva 888.89 Mn 888.89 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2024 3,230.66
Dec 31, 2023 6,455.64
Jun 30, 2023 6,533.55
Dec 31, 2022 6,121.48
Dec 31, 2018 625,485.24